What You Should Know:
- JLL, a professional services firm, announced the formation of its JLL Healthcare Center of Excellence to provide a deeper level of resources and specialized expertise to its health system and healthcare provider clients across the nation.
- The company has appointed Executive Managing Director Brannan Moss to lead this national initiative.
JLL Healthcare Center of Excellence & Leadership
The JLL Healthcare Center of Excellence (COE) will serve as a
Read More
Archives for April 2025
Metopio Secures Funding to Drive Data-Driven Solutions for Community Health
What You Should Know:
- Metopio has secured a multi-million-dollar investment led by Plymouth Growth, that promises to transform how organizations uncover, understand, and act on critical community insights.
- This strategic funding marks a pivotal moment in broadening access to data, empowering healthcare and public health professionals to make faster, more informed decisions that directly impact community well-being.
Metopio Secures Funding to Advance Community Intelligence
Read More
Samsung Partners With Stanford Medicine for New AI Sleep Apnea Feature
What You Should Know:
- Samsung Electronics and Stanford University today forms a research collaboration with Stanford Medicine aimed at developing health solutions leveraging Samsung’s recently FDA De Novo authorized obstructive sleep apnea (OSA) feature.
- The initiative, announced on World Health Day, underscores the critical role of sleep in overall well-being and marks a significant step towards proactive healthcare through pioneering research.
Advance Sleep Apnea
Read More
Kandu Health and Neurolutions Merge to Form Kandu, Inc.
What You Should Know:
- Kandu Health, Inc. and Neurolutions, Inc. today announced their merger, forming Kandu, Inc. The newly established company aims to redefine the landscape of stroke recovery by offering an unprecedented, at-home, end-to-end solution for stroke survivors and their caregivers.
- Kandu plans to develop a first-in-kind end-to-end solution for stroke survivors, combining brain computer interface (BCI) technology with personalized telehealth services.
$30M Funding
Read More
Teladoc Health Launches Next-Gen Cardiometabolic Health Program
What You Should Know:
- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today introduced its next generation Cardiometabolic Health Program to improve population health and prevent the progression of diabetes, hypertension and obesity.
- Building on the company’s industry-leading chronic condition management programs, the new offering is designed to support optimal cardiometabolic health for all populations.
Teladoc Health Expands Cardiometabolic Program to Improve
Read More
Doctors and Debt: Why Short Visits Create Long-Term Challenges
Doctors aren’t just healers—they’re involuntary lenders. Every time a physician treats a patient, they’re fronting the cost of care and hoping to get reimbursed. If the insurer underpays or denies the claim, the financial burden falls on the patient. And if the patient can’t pay? The doctor eats the loss.
No other profession operates like this. Imagine a contractor building a house and only finding out months later whether they’ll be paid, and how much. That’s how American healthcare works.
Read More
iCAD Appoints Mark Koeniguer as Chief Commercial Officer
What You Should Know:
- iCAD, Inc., a provider of clinically proven AI-powered breast health solutions, today announced the appointment of Mark Koeniguer as its Chief Commercial Officer (CCO).
- As CCO at iCAD, Koeniguer will oversee the commercial sales teams, strategic partnerships, operations, and customer success initiatives to drive revenue growth across North America and international markets.
Koeniguer Bio/Background
Mark Koeniguer joins iCAD with over 30
Read More
Phenomix Sciences Launches Clinical Trial to Predict GLP-1 Response Using Precision Obesity Test
What You Should Know:
- Phenomix Sciences (Phenomix), a commercial precision obesity medicine biotechnology company, today announced the initiation of its first prospective, placebo-controlled clinical study.
- The research will evaluate the MyPhenome™ test's ability to predict individual patient responses to semaglutide, a GLP-1-based therapy that has become a cornerstone in the treatment of obesity.
First Prospective Clinical Study of Semaglutide Using MyPhenome™
Read More
Transcarent Completes Merger With Accolade
What You Should Know:
- Transcarent today announced the successful completion of its merger with Accolade, a market leader in health advocacy, expert medical opinion, and virtual primary care.
- The newly combined organization, operating under the Transcarent name, now serves an impressive 20 million lives across more than 1,700 employer and health plan clients. This scale uniquely positions the company to address over 80 percent of an employer's healthcare spending by
Read More
MedeAnalytics, Socially Determined, and Mathematica Join Forces to Quantify the Impact of Social Determinants of Health
What You Should Know:
- MedeAnalytics, a healthcare enterprise data enrichment platform and analytics software-as-a-service (SaaS) provider, today announced a collaboration with Socially Determined and Mathematica.
- The strategic partnership aims to revolutionize the way the healthcare industry measures, validates, and understands the financial impact of interventions targeting social determinants of health (SDOH).
Transform Social Determinants of Health
Read More
